Baird Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-55,529
| Closed | -$1.21M | – | 1770 |
|
|
2025
Q1 | $1.21M | Buy |
55,529
+864
| +2% | +$18.9K | ﹤0.01% | 1115 |
|
|
2024
Q4 | $1.74M | Buy |
54,665
+27,495
| +101% | +$877K | ﹤0.01% | 1011 |
|
|
2024
Q3 | $784K | Buy |
27,170
+142
| +0.5% | +$4.1K | ﹤0.01% | 1245 |
|
|
2024
Q2 | $1.04M | Buy |
27,028
+481
| +2% | +$18.5K | ﹤0.01% | 1162 |
|
|
2024
Q1 | $1.56M | Buy |
26,547
+630
| +2% | +$37K | ﹤0.01% | 1025 |
|
|
2023
Q4 | $1.55M | Sell |
25,917
-15,361
| -37% | -$920K | ﹤0.01% | 1005 |
|
|
2023
Q3 | $1.57M | Buy |
41,278
+2,144
| +5% | +$81.6K | ﹤0.01% | 982 |
|
|
2023
Q2 | $3.57M | Sell |
39,134
-21,735
| -36% | -$1.98M | 0.01% | 732 |
|
|
2023
Q1 | $4.01M | Buy |
60,869
+21,392
| +54% | +$1.41M | 0.01% | 660 |
|
|
2022
Q4 | $2.04M | Buy |
39,477
+7,533
| +24% | +$389K | 0.01% | 869 |
|
|
2022
Q3 | $2.18M | Sell |
31,944
-6,828
| -18% | -$466K | 0.01% | 805 |
|
|
2022
Q2 | $1.75M | Sell |
38,772
-15,494
| -29% | -$701K | ﹤0.01% | 899 |
|
|
2022
Q1 | $2.76M | Buy |
54,266
+1,191
| +2% | +$60.5K | 0.01% | 782 |
|
|
2021
Q4 | $2.51M | Buy |
53,075
+22,377
| +73% | +$1.06M | 0.01% | 840 |
|
|
2021
Q3 | $1.01M | Buy |
30,698
+542
| +2% | +$17.9K | ﹤0.01% | 1196 |
|
|
2021
Q2 | $1.91M | Sell |
30,156
-8,121
| -21% | -$513K | 0.01% | 948 |
|
|
2021
Q1 | $1.64M | Buy |
38,277
+21,500
| +128% | +$922K | ﹤0.01% | 962 |
|
|
2020
Q4 | $960K | Sell |
16,777
-5,001
| -23% | -$286K | ﹤0.01% | 1013 |
|
|
2020
Q3 | $657K | Buy |
21,778
+75
| +0.3% | +$2.26K | ﹤0.01% | 1075 |
|
|
2020
Q2 | $709K | Buy |
21,703
+1,455
| +7% | +$47.5K | ﹤0.01% | 1050 |
|
|
2020
Q1 | $542K | Sell |
20,248
-4,375
| -18% | -$117K | ﹤0.01% | 1035 |
|
|
2019
Q4 | $754K | Sell |
24,623
-35,459
| -59% | -$1.09M | ﹤0.01% | 1056 |
|
|
2019
Q3 | $1.45M | Sell |
60,082
-5,147
| -8% | -$124K | 0.01% | 870 |
|
|
2019
Q2 | $1.65M | Buy |
+65,229
| New | +$1.65M | 0.01% | 834 |
|